M A Khan

Summary

Affiliation: Manion and Associates
Country: USA

Publications

  1. ncbi Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants
    M A Khan
    Hennepin County Medical Center, Division of Endocrinology, Minneapolis, MN 55415, USA
    Obes Res 8:43-8. 2000
  2. ncbi Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione
    J V St Peter
    Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
    Pharmacotherapy 21:183-8. 2001

Collaborators

  • J V St Peter
  • J T Vessey
  • K L Neafus
  • M S Lockheart

Detail Information

Publications2

  1. ncbi Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants
    M A Khan
    Hennepin County Medical Center, Division of Endocrinology, Minneapolis, MN 55415, USA
    Obes Res 8:43-8. 2000
    ..Characterize degree of weight loss with stage of diabetes and describe its effect on cardiovascular disease risk factors in obese patients with and without diabetes...
  2. ncbi Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione
    J V St Peter
    Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
    Pharmacotherapy 21:183-8. 2001
    ..03 and p=0.04, respectively). CONCLUSION: Several factors appear to increase the risk of enzyme elevation events in patients treated with troglitazone...